Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 3-broMo-5-Methoxybenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1095274-93-3

Post Buying Request

1095274-93-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1095274-93-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1095274-93-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,5,2,7 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1095274-93:
(9*1)+(8*0)+(7*9)+(6*5)+(5*2)+(4*7)+(3*4)+(2*9)+(1*3)=173
173 % 10 = 3
So 1095274-93-3 is a valid CAS Registry Number.

1095274-93-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-bromo-5-methoxybenzoate

1.2 Other means of identification

Product number -
Other names ethyl 3-bromo-5-(methyloxy)benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1095274-93-3 SDS

1095274-93-3Relevant academic research and scientific papers

NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

-

Paragraph 00324, (2014/12/12)

The present invention is directed to novel compounds, pharmaceutical compositions comprising such compounds, and the methods of making and using the same. These compounds are useful as modulators of Cystic Fibrosis Transmembrane Conductor Regulator (CFTR). The present invention also relates to methods of treating or lessening the severity of cystic fibrosis in a patient. These compounds may be used alone or in combination with one or more secondary active agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1095274-93-3